Table of Content




1. Executive Summary


2. Global Diagnostic Exosome Biomarker Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Diagnostic Exosome Biomarker Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Diagnostic Exosome Biomarker Market by Product Type
3.3.1: Reagents
3.3.2: Kits
3.3.3: Serum/Plasma Kits
3.3.4: Urine Kits
3.3.5: Software

3.4: Global Diagnostic Exosome Biomarker Market by Application
3.4.1: Neurodegenerative Disorders
3.4.2: Oncology
3.4.3: Metabolic Disorders
3.4.4: Others


3.5: Global Diagnostic Exosome Biomarker Market by End Use
3.5.1: Cancer Institutes
3.5.2: Hospitals
3.5.3: Diagnostic Centers
3.5.4: Others




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Diagnostic Exosome Biomarker Market by Region
4.2: North American Diagnostic Exosome Biomarker Market
4.2.1: North American Diagnostic Exosome Biomarker Market by Product Type: Reagents, Kits, Serum/Plasma Kits, Urine Kits, and Software
4.2.2: North American Diagnostic Exosome Biomarker Market by End Use: Cancer Institutes, Hospitals, Diagnostic Centers, and Others

4.3: European Diagnostic Exosome Biomarker Market
4.3.1: European Diagnostic Exosome Biomarker Market by Product Type: Reagents, Kits, Serum/Plasma Kits, Urine Kits, and Software
4.3.2: European Diagnostic Exosome Biomarker Market by End Use: Cancer Institutes, Hospitals, Diagnostic Centers, and Others

4.4: APAC Diagnostic Exosome Biomarker Market
4.4.1: APAC Diagnostic Exosome Biomarker Market by Product Type: Reagents, Kits, Serum/Plasma Kits, Urine Kits, and Software
4.4.2: APAC Diagnostic Exosome Biomarker Market by End Use: Cancer Institutes, Hospitals, Diagnostic Centers, and Others

4.5: ROW Diagnostic Exosome Biomarker Market
4.5.1: ROW Diagnostic Exosome Biomarker Market by Product Type: Reagents, Kits, Serum/Plasma Kits, Urine Kits, and Software
4.5.2: ROW Diagnostic Exosome Biomarker Market by End Use: Cancer Institutes, Hospitals, Diagnostic Centers, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Diagnostic Exosome Biomarker Market by Product Type
6.1.2: Growth Opportunities for the Global Diagnostic Exosome Biomarker Market by Application
6.1.3: Growth Opportunities for the Global Diagnostic Exosome Biomarker Market by End Use
6.1.4: Growth Opportunities for the Global Diagnostic Exosome Biomarker Market by Region

6.2: Emerging Trends in the Global Diagnostic Exosome Biomarker Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Diagnostic Exosome Biomarker Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diagnostic Exosome Biomarker Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Codiak Biosciences
7.2: Exosome Diagnostics
7.3: Evox Therapeutics
7.4: Anjarium Biosciences
7.5: Xollent
7.6: Craif
7.7: Carmine Therapeutics